Neurological Disorders

Also known as: Neurological Disorder

DrugDrug NameDrug Description
DB00370MirtazapineMirtazapine is a tetracyclic _piperazino-azepine_ antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.[A177946] This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major depressive disorder.[T595, L6157] The effects of this drug may be observed as early as 1 week after beginning therapy.[A178144,L6160] In addition to its beneficial effects in depression, mirtazapine has been reported to be efficacious in the off-label management of various other conditions. It may improve the symptoms of neurological disorders, reverse weight loss caused by medical conditions, improve sleep, and prevent nausea and vomiting after surgery.[A177811]
DrugDrug NamePhaseStatusCount
DB09270Ubidecarenone2 / 3Completed1
DB00993AzathioprineNot AvailableRecruiting1
DB00688Mycophenolate mofetilNot AvailableRecruiting1
DB00495ZidovudineNot AvailableRecruiting1